No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED).

scientific article published in November 2007

No changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED). is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.17305/BJBMS.2007.3027
P932PMC publication ID5728611
P698PubMed publication ID18039196

P2093author name stringMagdalena Antova
Milco Bogoev
Nevenka Laban-Guceva
P2860cites workClinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approachQ33647383
Natural history of thyroid associated ophthalmopathyQ34059445
Treating severe Graves' ophthalmopathyQ41734163
The 64-kilodalton eye muscle protein is the flavoprotein subunit of mitochondrial succinate dehydrogenase: the corresponding serum antibodies are good markers of an immune-mediated damage to the eye muscle in patients with Graves' hyperthyroidismQ42672581
Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroidsQ43831067
Role of the eye muscles in thyroid eye disease: identification of the principal autoantigens.Q47822465
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.Q50933902
The treatment of Graves' ophthalmopathy in an incidence cohort.Q51034070
Thyroid stimulating antibody in sera of Graves' ophthalmopathy patients as a possible marker for predicting the efficacy of methylprednisolone pulse therapy.Q64881547
Stimulation of glycosaminoglycan accumulation by interferon gamma in cultured human retroocular fibroblastsQ67987168
Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathyQ69288448
Current trends in orbital decompressionQ69801652
Thyrotropin receptor in non-thyroid tissuesQ70575577
Characterization of adhesion receptors on cultured microvascular endothelial cells derived from the retroorbital connective tissue of patients with Grave's ophthalmopathyQ70976102
Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathyQ71637864
Expression of thyrotropin-receptor mRNA in healthy and Graves' disease retro-orbital tissueQ72226506
Randomized double-blind trial of prednisone versus radiotherapy in Graves' ophthalmopathyQ72235149
Therapeutic controversies. Retrobulbar radiation in Graves' ophthalmopathyQ72536550
Results of transantral orbital decompression in 428 patients with severe Graves' ophthalmopathyQ72602506
TSH-R expression and cytokine profile in orbital tissue of active vs. inactive Graves' ophthalmopathy patientsQ73055258
Effect of radioactive iodine therapy on cytokine production in Graves' disease: transient increases in interleukin-4 (IL-4), IL-6, IL-10, and tumor necrosis factor-alpha, with longer term increases in interferon-gamma productionQ73194244
Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathyQ73555606
Soluble interleukin-1 receptor antagonist concentration in patients with Graves' ophthalmopathy is neither related to cigarette smoking nor predictive of subsequent response to glucocorticoidsQ73738586
Reevaluation of the prevalences of serum autoantibodies reactive with "64-kd eye muscle proteins" in patients with thyroid-associated ophthalmopathyQ74336326
Possible involvement of Fas-mediated apoptosis in eye muscle tissue from patients with thyroid-associated ophthalmopathyQ74551700
Orbital radiotherapy for Graves' ophthalmopathyQ74638517
Has the target autoantigen for Graves' ophthalmopathy been found?Q77326677
Current management of thyroid-associated ophthalmopathy in Europe. Results of an international surveyQ77495701
P433issue4
P407language of work or nameEnglishQ1860
P921main subjecteye diseaseQ3041498
P304page(s)358-362
P577publication date2007-11-01
P1433published inBosnian Journal of Basic Medical SciencesQ4947405
P1476titleNo changes in serum concentrations of interleukin 10 (IL-10) and interferon gamma (IF-gamma) before and after treatment of the thyroid eye disease (TED).
P478volume7

Search more.